NovoCure Limited Dilutive Securities, Effect on Basic Earnings Per Share
NovoCure Limited (NVCR) reported Dilutive Securities, Effect on Basic Earnings Per Share of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:DilutiveSecurities · last filed 2026-02-26
- NovoCure Limited dilutive securities, effect on basic earnings per share for fiscal 2025 was $0.00.
- NovoCure Limited dilutive securities, effect on basic earnings per share for fiscal 2024 was $0.00.
- NovoCure Limited dilutive securities, effect on basic earnings per share for fiscal 2023 was $0.00.
- NovoCure Limited dilutive securities, effect on basic earnings per share for fiscal 2022 was $0.00.
| Period end | Dilutive Securities, Effect on Basic Earnings Per Share 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2022-12-31 | $0.00 10-K · filed 2025-02-27 |
| 2021-12-31 | $0.00 10-K · filed 2024-02-22 |
| 2020-12-31 | $0.00 10-K · filed 2023-02-23 |
| 2019-12-31 | $0.00 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |